Real-life Treatment Outcomes of Ravulizumab in PNH

Last updated: November 14, 2025
Sponsor: AstraZeneca
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Anemia

Hemoglobinuria, Paroxysmal

Proteinuria

Treatment

Ravulizumab

Clinical Study ID

NCT06633536
D9289R00001
  • Ages > 18
  • All Genders

Study Summary

The PNH-RECORD study, a Polish multicenter observational (non-interventional), open-label, retrospective with prospective follow-up.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Adult (aged ≥18) patients with PNH receiving ravulizumab treatment in the frames ofNDP in Poland.

  2. Patients willing to participate in the study and signed ICF.

Exclusion

Exclusion Criteria:

  1. Those who participated in ravulizumab clinical trial in the past, and/or those whoparticipated/plans to participate in clinical trial on/after the date of firstravulizumab infusion through NDP.

  2. Cognitive incapacity, unwillingness or language barriers precluding adequateunderstanding or cooperation.

Study Design

Total Participants: 64
Treatment Group(s): 1
Primary Treatment: Ravulizumab
Phase:
Study Start date:
February 06, 2025
Estimated Completion Date:
August 01, 2028

Study Description

PNH-RECORD study aims to aims to collect data on the patients' characteristics and clinical outcomes of ravulizumab administered in the scope of routine clinical practice in PNH.

Connect with a study center

  • Research Site

    Bialystok,
    Poland

    Site Not Available

  • Research Site

    Bialystok 776069,
    Poland

    Site Not Available

  • Research Site

    Brzozow,
    Poland

    Site Not Available

  • Research Site

    Brzozów 775086,
    Poland

    Site Not Available

  • Research Site

    Bydgoszcz,
    Poland

    Site Not Available

  • Research Site

    Bydgoszcz 3102014,
    Poland

    Site Not Available

  • Research Site

    Gdansk,
    Poland

    Site Not Available

  • Research Site

    Gdansk 3099434,
    Poland

    Site Not Available

  • Research Site

    Katowice,
    Poland

    Site Not Available

  • Research Site

    Katowice 3096472,
    Poland

    Site Not Available

  • Research Site

    Krakow,
    Poland

    Site Not Available

  • Research Site

    Krakow 3094802,
    Poland

    Site Not Available

  • Research Site

    Lodz,
    Poland

    Site Not Available

  • Research Site

    Lodz 3093133,
    Poland

    Site Not Available

  • Research Site

    Lublin,
    Poland

    Site Not Available

  • Research Site

    Lublin 765876,
    Poland

    Site Not Available

  • Research Site

    Opole,
    Poland

    Site Not Available

  • Research Site

    Opole 3090048,
    Poland

    Site Not Available

  • Research Site

    Szczecin,
    Poland

    Site Not Available

  • Research Site

    Szczecin 3083829,
    Poland

    Site Not Available

  • Research Site

    Walbrzych,
    Poland

    Site Not Available

  • Research Site

    Warsaw,
    Poland

    Site Not Available

  • Research Site

    Warsaw 756135,
    Poland

    Site Not Available

  • Research Site

    Wałbrzych 3082707,
    Poland

    Site Not Available

  • Research Site

    Wroclaw,
    Poland

    Site Not Available

  • Research Site

    Wroclaw 3081368,
    Poland

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.